載入...
The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative
Drug induced liver injury (DILI) is a rare but well recognized serious adverse reaction. Pre-marketing studies may not detect liver injury, and DILI becomes very often apparent after the drug is launched to the market. Specific biomarkers for DILI prediction or diagnosis are not available. Toxic liv...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4813176/ https://ncbi.nlm.nih.gov/pubmed/26938524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17030313 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|